Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BACKGROUND: Mineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. METHODS AND RESULTS: In order to better understand MRA use and subsequent outcomes, we perform...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Fudim, Marat, Liu, Peter R., Shrader, Peter, Blanco, Rosalia G., Allen, Larry A., Fonarow, Gregg C., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Hylek, Elaine, Go, Alan S., Thomas, Laine, Peterson, Eric D., Piccini, Jonathan P.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015424/
https://ncbi.nlm.nih.gov/pubmed/29654203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados